Infezione da virus dell'epatite C (HCV) e trapianto renale

Translated title of the contribution: Hepatitis C virus and renal transplantation

F. Fabrizi, Paul Martin, G. Lunghi, A. Aroldi, P. G. Messa

Research output: Contribution to journalArticlepeer-review


Liver disease has emerged as an important cause of morbidity and mortality after renal transplantation (RT). Hepatitis C virus (HCV) is the leading cause of liver disease after RT. The impact of HCV infection on patient and graft survival is currently a major concern. Retrospective studies with appropriate follow-up have mainly demonstrated that HCV positive patients have greater mortality compared to HCV negative recipients after RT. Novel investigations by large databases (United States Renal Data Systems (USRDS)) have shown that recipients of donor HCV-positive kidneys are at an independently increased risk of mortality, adjusted hazard ratio 2.12 (95% confidence interval (95% CI), 1.72-2.87, p

Translated title of the contributionHepatitis C virus and renal transplantation
Original languageItalian
Pages (from-to)429-437
Number of pages9
JournalGiornale italiano di nefrologia : organo ufficiale della Società italiana di nefrologia
Issue number5
StatePublished - Sep 1 2004
Externally publishedYes

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Hepatitis C virus and renal transplantation'. Together they form a unique fingerprint.

Cite this